Robert Doebele is Officer of Rain Therapeutics Inc.. Currently has a direct ownership of 0 shares of RAIN, which is worth approximately $0. The most recent transaction as insider was on Jan 26, 2024, when has been sold 476,827 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Robert Doebele Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
476,827 Reduced 100.0%
0 Common Stock, par valu...
Jul 06 2022
BUY
Exercise of conversion of derivative security
$15,366 $3.95 p/Share
3,890 Added 0.81%
476,827 Common Stock
Apr 13 2022
BUY
Exercise of conversion of derivative security
$11,850 $3.95 p/Share
3,000 Added 0.63%
472,937 Common Stock
Mar 31 2022
BUY
Exercise of conversion of derivative security
$7,900 $3.95 p/Share
2,000 Added 0.42%
469,937 Common Stock
Apr 27 2021
BUY
Conversion of derivative security
-
4,932 Added 1.04%
467,937 Common Stock
RD

Robert Doebele

Officer
Newark, CA

Track Institutional and Insider Activities on RAIN

Follow Rain Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RAIN shares.

Notify only if

Insider Trading

Get notified when an Rain Therapeutics Inc. insider buys or sells RAIN shares.

Notify only if

News

Receive news related to Rain Therapeutics Inc.

Track Activities on RAIN